文献速递肝胆胰外科围术期管理与 ERAS

机器人对比腹腔镜解剖性肝切除:ROC'N'ROLL随机对照试验的事后分析

Robotic versus laparoscopic anatomical hepatectomy: a post hoc analysis of the ROC'N'ROLL randomized controlled trial.
PubMed 文献 · Surg Endosc · 2026-09-29

该研究为ROC'N'ROLL随机对照试验的探索性事后分析,纳入57例计划行微创解剖性肝切除的患者(机器人组30例,腹腔镜组27例)。机器人组90天内严重并发症发生率为13%,腹腔镜组为37%(OR 0.27,95%CI 0.07-0.97,P=0.045),但机器人组肿瘤更大且IWATE难度评分更高,手术时间更长。结论认为机器人解剖性肝切除与更少严重并发症相关,但需前瞻性验证。

要点

  • 机器人解剖性肝切除严重并发症(Clavien-Dindo≥III)发生率低于腹腔镜(13% vs 37%,OR 0.27)。
  • 机器人组肿瘤更大(中位59 vs 40 mm,P=0.048)且IWATE难度评分更高(中位10 vs 7,P=0.029)。
  • 机器人组手术时间更长(中位252 vs 190 min,P=0.021),其他结局无明确组间差异。

核心结论

  • 机器人解剖性肝切除尽管手术复杂度更高,但与更少的严重并发症相关。
  • 这些探索性发现支持在高难度病例中使用机器人解剖性肝切除,但需要前瞻性验证。

研究设计与样本

  • ROC'N'ROLL随机对照试验的探索性事后分析,纳入随机化前计划行微创解剖性肝切除的患者。
  • 共57例患者纳入分析,机器人解剖性肝切除组30例,腹腔镜解剖性肝切除组27例。
  • 主要终点为90天内严重术后并发症(Clavien-Dindo分级≥III)发生率。
  • 未进行亚组特异性样本量计算。

主要发现

  • 机器人组严重并发症发生率为13%,腹腔镜组为37%(OR 0.27,95%CI 0.07-0.97,P=0.045)。
  • 机器人组肿瘤中位大小59 mm,腹腔镜组40 mm(P=0.048);机器人组IWATE难度评分中位10,腹腔镜组7(P=0.029)。
  • 机器人组手术时间中位252 min,腹腔镜组190 min(P=0.021)。
  • 两组在转换率、出血量、住院时间、功能恢复、切缘状态、死亡率和患者报告结局方面未观察到明确组间差异。

临床怎么用

  • 对于高难度解剖性肝切除病例,机器人入路可能降低严重并发症风险,但需结合团队经验与资源条件个体化选择。
  • 解读结果时应考虑基线不平衡(机器人组肿瘤更大、难度评分更高)和事后分析的探索性性质。

局限性

  • 为随机对照试验的探索性事后分析,未进行亚组特异性样本量计算。
  • 存在基线不平衡,机器人组肿瘤更大且IWATE难度评分更高。
  • 样本量较小(共57例),结果需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic liver surgery may overcome technical limitations of laparoscopic approaches, particularly for anatomical hepatectomy. Comparative prospective data remain limited. METHODS: This exploratory post hoc analysis of the ROC'N'ROLL randomized controlled trial included patients scheduled for minimally invasive anatomical hepatectomy before randomization. Participants were randomized to robotic (RAH) or laparoscopic anatomical hepatectomy (LAH). The primary endpoint of this analysis was the rate of severe postoperative complications (Clavien-Dindo grade ≥ III) within 90 days. No subgroup-specific sample size calculation was performed. Secondary outcomes included conversion, operative time, blood loss, oncological outcomes, recovery, and patient-reported outcomes (PROs). RESULTS: Among 81 randomized participants, 57 were scheduled for anatomical hepatectomy (RAH, n = 30; LAH, n = 27). Baseline imbalances were present, with larger tumors in the RAH group (median, 59 vs 40 mm; P = 0.048) and higher IWATE difficulty scores (median, 10 vs 7; P = 0.029). Operating time was longer with RAH (median, 252 vs 190 min; P = 0.021). Severe complications occurred in 13% after RAH and 37% after LAH (odds ratio, 0.27; 95% CI, 0.07-0.97; P = 0.045). No clear between-group differences were observed in conversion, blood loss, length of stay, functional recovery, margin status, mortality, or PROs. CONCLUSIONS: Robotic anatomical hepatectomy was associated with fewer severe complications despite higher procedural complexity. These exploratory findings support its use in high-difficulty cases but require prospective validation. (DRKS00027531).

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Birgin E, Heibel M, Hetjens S, et al. Robotic versus laparoscopic anatomical hepatectomy: a post hoc analysis of the ROC'N'ROLL randomized controlled trial. Surg Endosc. 2026. PMID: 42811178. doi:10.1007/s00464-026-13425-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。